ATE252371T1 - Verfahren für die herstellung einer biologisch aktiven zusammensetzung - Google Patents

Verfahren für die herstellung einer biologisch aktiven zusammensetzung

Info

Publication number
ATE252371T1
ATE252371T1 AT99927062T AT99927062T ATE252371T1 AT E252371 T1 ATE252371 T1 AT E252371T1 AT 99927062 T AT99927062 T AT 99927062T AT 99927062 T AT99927062 T AT 99927062T AT E252371 T1 ATE252371 T1 AT E252371T1
Authority
AT
Austria
Prior art keywords
biologically active
active agent
carrier
producing
chemical operation
Prior art date
Application number
AT99927062T
Other languages
English (en)
Inventor
Ke Lindahl
H Kan Hagslaett
Catharina Heiman
Rickard Bryland
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of ATE252371T1 publication Critical patent/ATE252371T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
AT99927062T 1998-05-14 1999-05-12 Verfahren für die herstellung einer biologisch aktiven zusammensetzung ATE252371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (1)

Publication Number Publication Date
ATE252371T1 true ATE252371T1 (de) 2003-11-15

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99927062T ATE252371T1 (de) 1998-05-14 1999-05-12 Verfahren für die herstellung einer biologisch aktiven zusammensetzung

Country Status (20)

Country Link
EP (1) EP1077677B1 (de)
JP (1) JP2002514588A (de)
KR (1) KR100766998B1 (de)
CN (1) CN1309554A (de)
AT (1) ATE252371T1 (de)
AU (1) AU742921B2 (de)
CA (1) CA2332110A1 (de)
DE (2) DE69912271T2 (de)
DK (1) DK1077677T3 (de)
ES (1) ES2155049T3 (de)
GR (1) GR20010300014T1 (de)
HU (1) HUP0102002A3 (de)
IL (2) IL139577A0 (de)
NO (1) NO20005725L (de)
NZ (1) NZ508074A (de)
PL (1) PL344221A1 (de)
SE (1) SE9801705D0 (de)
TR (1) TR200003588T2 (de)
WO (1) WO1999058109A1 (de)
ZA (1) ZA200006476B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280485A4 (de) * 2000-02-29 2006-11-29 Zars Inc Verbessertes transdermales medizinpflaster
CA2534367A1 (en) 2003-08-06 2005-02-17 Nirmal Mulye Pharmaceutical composition containing water soluble drug
KR20090031726A (ko) 2006-06-14 2009-03-27 닥터 레디스 레보러터리즈 리미티드 국소용 조성물
JP2013536884A (ja) * 2010-08-31 2013-09-26 ビーエーエスエフ ソシエタス・ヨーロピア クエン酸に基づいた分枝ポリエステル、さらにはそれらの製造及び使用
US20130289089A1 (en) * 2011-01-13 2013-10-31 Jerome A. Morris Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
HUP0102002A3 (en) 2002-12-28
DE1077677T1 (de) 2001-09-20
TR200003588T2 (tr) 2001-06-21
ES2155049T1 (es) 2001-05-01
PL344221A1 (en) 2001-10-08
NO20005725D0 (no) 2000-11-13
JP2002514588A (ja) 2002-05-21
EP1077677A1 (de) 2001-02-28
IL139577A0 (en) 2002-02-10
SE9801705D0 (sv) 1998-05-14
DK1077677T3 (da) 2004-02-16
DE69912271D1 (de) 2003-11-27
KR100766998B1 (ko) 2007-10-15
DE69912271T2 (de) 2004-08-26
CA2332110A1 (en) 1999-11-18
IL139577A (en) 2007-07-04
HUP0102002A2 (hu) 2002-03-28
ZA200006476B (en) 2001-06-11
CN1309554A (zh) 2001-08-22
KR20010052349A (ko) 2001-06-25
ES2155049T3 (es) 2004-05-16
AU4405199A (en) 1999-11-29
EP1077677B1 (de) 2003-10-22
GR20010300014T1 (en) 2001-04-30
AU742921B2 (en) 2002-01-17
NO20005725L (no) 2001-01-11
WO1999058109A1 (en) 1999-11-18
NZ508074A (en) 2003-01-31

Similar Documents

Publication Publication Date Title
DE69722963D1 (de) Verfahren zur herstellung von vorrichtungen für kontrollierte freisetzung
DE59607548D1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
ATE113609T1 (de) Material aus karboxylgruppen enthaltenden polysacchariden, sowie verfahren zur herstellung solcher polysaccharide.
DE69614689T2 (de) Zusammensetzung, die ein in einem glasbildenden träger gelösten wirkstoff enthalt und ein verfahren zu deren herstellung
JPS54101795A (en) Hydrophobic rendering method for oxide fine powder
DE69124357T2 (de) Protein Nanomatrizen und Verfahren zur Herstellung
ATE169895T1 (de) Verfahren zur behandlung eines flüssigen stickstoffreichen abfallprodukts,nach diesem verfahren hergestellte düngemittellösung sowie seine herstellung
CA2407684A1 (en) Hematology blood control and method for preparation of same
DE60041876D1 (de) Polyurethanderivatzusammensetzungen und Verfahren zu ihrer Herstellung
ATE326437T1 (de) Beschichtungszusammensetzung, insbesondere für glasoberflächen, und verfahren zu deren herstellung und verwendung
ATE252371T1 (de) Verfahren für die herstellung einer biologisch aktiven zusammensetzung
ATE242282T1 (de) Verfahren zur maskierung von in emulsion vorliegenden polyisocyanaten
GB2315745A (en) Hydraulic cement set accelerators based on nitroalcohols
ATE310500T1 (de) Biologisch aktive zusammensetzung
DE59905671D1 (de) Verfahren zur herstellung eines schaumstoffes
DE59508911D1 (de) Verfahren zur herstellung von vorrichtungen zur kontrollierten freisetzung von wirkstoffen
KR910002493A (ko) 다공질화산암(多孔質火山岩)을 활용한 공해방지제 (公害防止劑)의 제조방법
NZ512530A (en) Composition including citric acid and an organic thickening agent, and a method for removing a cementitious substance (e.g. concrete) from a surface
JPS5325267A (en) Removing method for oxygen existing in aqueous system
JPS53149867A (en) Treating method for waste fluid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1077677

Country of ref document: EP